GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Ending Cash Position

International Biotechnology Trust (LSE:IBT) Ending Cash Position : £9.23 Mil (As of Feb. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Ending Cash Position?

International Biotechnology Trust's Ending Cash Position for the quarter that ended in Feb. 2024 was £9.23 Mil.

International Biotechnology Trust's quarterly Ending Cash Position declined from Feb. 2023 (£-24.19 Mil) to Aug. 2023 (£-32.47 Mil) but then increased from Aug. 2023 (£-32.47 Mil) to Feb. 2024 (£9.23 Mil).

International Biotechnology Trust's annual Ending Cash Position declined from Aug. 2021 (£-20.31 Mil) to Aug. 2022 (£-39.98 Mil) but then increased from Aug. 2022 (£-39.98 Mil) to Aug. 2023 (£-32.47 Mil).


International Biotechnology Trust Ending Cash Position Historical Data

The historical data trend for International Biotechnology Trust's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Ending Cash Position Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 -17.77 -20.31 -39.98 -32.47

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.14 -39.98 -24.19 -32.47 9.23

International Biotechnology Trust Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

International Biotechnology Trust's Ending Cash Position for the fiscal year that ended in Aug. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=-39.976+7.502
=-32.47

International Biotechnology Trust's Ending Cash Position for the quarter that ended in Feb. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=-32.474+41.701
=9.23


International Biotechnology Trust Ending Cash Position Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines

No Headlines